Alves de Paula e Silva, Ana Carolina [UNESP]Costa-Orlandi, Caroline Barcelos [UNESP]Gullo, Fernanda Patricia [UNESP]Sangalli-Leite, Fernanda [UNESP]Oliveira, Haroldo Cesar de [UNESP]Silva, Julhiany de Fatima da [UNESP]Scorzoni, Liliana [UNESP]Pitangui, Nayla de Souza [UNESP]Rossi, Suelen Andrea [UNESP]Benaducci, Tatiane [UNESP]Wolf, Vanessa Goncalves [UNESP]Regasini, Luis Octavio [UNESP]Petronio, Maicon Segalla [UNESP]Siqueira Silva, Dulce Helena [UNESP]Bolzani, Vanderlan da Silva [UNESP]Fusco-Almeida, Ana Marisa [UNESP]Mendes-Giannini, Maria José Soares [UNESP]2015-03-182015-03-182014-01-01Evidence-based Complementary And Alternative Medicine. New York: Hindawi Publishing Corporation, 8 p., 2014.1741-427Xhttp://hdl.handle.net/11449/117233This work aims to demonstrate that the gallic acid structure modification to the decyl gallate (G14) compound contributed to increase the antifungal activity against several species of pathogenic fungi, mainly, Candida spp., Cryptococcus spp., Paracoccidioides spp., and Histoplasma capsulatum, according to standardized microdilution method described by Clinical Laboratory Standard Institute (CLSI) documents. Moreover this compound has a particularly good selectivity index value, which makes it an excellent candidate for broad-spectrum antifungal prototype and encourages the continuation of subsequent studies for the discovery of its mechanism of action.8engArtigo10.1155/2014/506273WOS:000345755800001Acesso abertoWOS000345755800001.pdfWOS000345755800001.epub470200490423124844840836852516730000-0002-8059-0826